.jpg)
Faced with high drug prices, seniors are abandoning cancer drugs at the pharmacy
The pressure on Medicare just keeps ramping up Medicare is set to decide this month…
Author: STAT
STAT+: Troubles mount for Cassava Sciences, as patient enrollment lags for Alzheimer’s drug studies
Cassava Sciences conceded Tuesday that only a relative handful of patients with Alzheimer’s have been…
STAT+: Pharmalittle: Bluebird axes nearly one-third of its employees; Senate committee probes Merck’s tax practices
Hello, everyone, and how are you today? A cloudy cover greeted us this morning, but…
STAT+: Bluebird, troubled gene therapy maker, to lay off employees and reduce costs
Bluebird Bio is reducing expenses and laying off nearly a third of its employees to…
STAT+: Douglas Melton, noted stem cell researcher, leaves Harvard for Vertex to create diabetes treatments
Douglas Melton, one of the leading stem cell researchers in the world, is leaving Harvard…
Opinion: In the future, we should spend more on prescription drugs, not less
The conventional wisdom that we need to reduce spending on prescription drugs is all wrong….
Opinion: Home care instead of hospital care: Congress should extend a crucial waiver
Hospitals can be places of healing and, at times, harm, particularly for older adults with…
‘We don’t have a say’: Siobhan Wescott wants to elevate the voices of Native Americans in public health
As the first endowed professor and director of American Indian health at the University of…
STAT+: When a dire text message interrupted his talk, this doctor’s cancer research became painfully real
SAN DIEGO — If you’d seen him, you wouldn’t have known Scott Lippman was living…
STAT+: Biden administration funnels one of the largest-ever pay increases to Medicare Advantage insurers
The federal government is boosting the average payment to Medicare Advantage plans by 5% for…
STAT+: Hospital prices are soaring especially fast in Northern California. Here’s why
California’s lawmakers have spent decades crafting well-intentioned rules designed to keep the state’s healthcare prices…
STAT+: Wyden wants details on Merck’s U.S. taxes as part of expanding probe into pharma practices
The head of the U.S. Senate Finance Committee is seeking details from Merck about the…
STAT+: Medicare Part D and its beneficiaries could have saved millions if more biosimilars were accessible
Amid ongoing debate over biosimilar use in the United States, a new government analysis found…
STAT+: Pharmalittle: Novartis reorganizes and hopes to save $1 billion; industry-backed antibiotic fund makes first investments
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
NIH’s cancer chief, Ned Sharpless, to step down
Ned Sharpless, the director of the National Cancer Institute, is stepping down at the end…
STAT+: Pharma’s ambitious new antibiotic venture fund makes its first investments
One year after its splashy launch, the AMR Action Fund has made its first investments…
Opinion: Equal treatment for equal risk: Should race be included in allocation algorithms for Covid-19 therapies?
When the Omicron surge threatened to overwhelm hospitals and the number of infections greatly exceeded…
Listen: How one 1910 report curtailed Black medical education for over a century
Medicine in America underwent a radical transformation in 1910. This was the year the Flexner…
Research on mice that ‘sweat out’ fat wins STAT Madness for University of Pennsylvania
Pizza rat, watch out: pizza-faced mice are on their way to stealing your crown. A…
STAT+: The biotech scorecard for the second quarter: 21 stock-moving events to watch
Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the second…
Moving xenotransplantation research into human trials will require adjusting our expectations, researchers say
On the heels of some important “firsts” this past year, xenotransplantation — grafting animal organs…
STAT+: Pharmalittle: Califf admits Alzheimer’s drug controversy has hurt expert trust in FDA; House passes bill to lower insulin costs
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Mark Cuban’s company is building a ‘parallel supply chain’ for prescription drugs
Mark Cuban’s drug company started with an ambitious premise: to circumvent middlemen to offer cheaper…
STAT+: In the wake of Covid, a World Health Assembly proposal would bolster quality of clinical trials
Ahead of a World Health Assembly meeting in May, the United Kingdom is circulating a…
‘Skinny, greasy mice,’ artificial cells and tumor mapping: Researchers vie for STAT Madness championship
Were the oily rodents impressive enough? More amazing than the family tree of tumors? Than…
Opinion: Digital health is overlooking its biggest opportunity for disruption
For years, tech behemoths and digital health innovators have attempted to “reinvent” health care, but…
Opinion: Narrowing the vaccine gap as boosters begin for people over 50
The Food and Drug Administration this week authorized a second booster for individuals 50 and…
As research grows on primary care and serious mental illness, a glaring gap remains
Laura Brown knows that she has high cholesterol, and that as someone who lives with…
STAT+: The health tech tracker for the second quarter: the decisive industry deals and events to watch
As another Covid winter turns to spring, we’ll be watching to see whether 2022’s wave…
Senate nears $10 billion deal to buy Covid vaccines, therapeutics
WASHINGTON — Top Senate negotiators are working to reach a deal to provide the Biden…
Califf admits the FDA’s Alzheimer’s drug decision impacted experts’ trust in the agency
WASHINGTON — Robert Califf, the new head of the Food and Drug Administration, admitted Thursday…
In the wake of big patent decision, it’s business as usual for CRISPR therapy developers
Earlier this month, the U.S. Patent and Trademark Office ruled that CRISPR patents key to…
Pandemic took a toll on teen mental health, CDC report says
NEW YORK — More than 4 in 10 U.S. high school students said they felt…
.jpg)
Health tech takes aim at Alzheimer’s and home care startups to watch
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
STAT+: Biden’s high-stakes biomedical science agency ARPA-H will be part of the NIH — but there’s a twist
WASHINGTON — President Biden’s “moonshot” biomedical research agency will be housed within the National Institutes…
STAT+: Pharmalittle: Advisory panel narrowly votes down ALS drug; Vertex looks to advance experimental pain drug
Good morning. Elizabeth Cooney here, borrowing the virtual Pharmalittle chair while Ed Silverman takes Manhattan…
STAT+: Vertex’s non-opioid painkiller meets goals in mid-stage studies
A novel pain drug from Vertex Pharmaceuticals met its goals in two mid-stage trials, the…
Opinion: What health care must learn from meteorology about the importance of R2O
Twenty years ago, a board of atmospheric experts published a report that revolutionized the meteorology…
STAT+: 5 technology trends drawing investment as health care moves into the home
With Medicare expected to cover a projected 80 million people by 2030, entrepreneurs and investors…
Even as medicine becomes more diverse, main authors in elite journals remain mostly white and male
A new analysis of two of the nation’s most prestigious medical journals shows that women…
With pharma still struggling in Alzheimer’s, health tech companies want a swing
In the wake of the first Alzheimer’s drug approval in nearly two decades, pharmaceutical companies…
STAT+: By narrow margin, FDA advisory panel concludes Amylyx ALS drug hasn’t proven effectiveness
For archived live coverage of the hearing of the FDA’s advisory panel, click here. By…
STAT+: Pharma companies face shareholder proposals to widen access to medicines, rework business plans
Over the next few weeks, several major pharmaceutical companies will face a fresh crop of…
STAT+: CVS, Teva, and Allergan reach massive deal with Florida over the opioid crisis
On the eve of a trial, the state of Florida has reached a massive settlement…
Obesity can turn a helpful immunotherapy into a harmful one, mouse study shows
Researchers have long known that obesity rewires the immune system. Now a new study suggests…
STAT+: Pharmalittle: Roche immunotherapy fails its first test; key U.S. senators move closer to bill to cap insulin prices
Hello, everyone, and how are you this fine, sunny morning? The middle of the week…
STAT+: Roche anti-TIGIT cancer immunotherapy fails in first late-stage clinical trial
Roche said Wednesday that an experimental cancer immunotherapy directed against a target called TIGIT failed…
STAT+: Tracking the FDA advisory panel on Amylyx Pharma’s ALS treatment
The Food and Drug Administration is convening a meeting of outside experts today to review…
Opinion: Listen: Tom Sequist on mirrored Covid tragedies — 2,000 miles apart
Like many of us, Tom Sequist had no idea what was about to happen as…
Opinion: There’s no return to normal for millions of children orphaned during Covid
Forgotten in the calls for a “new normal” and the shuffle toward it are the…